Topamax: Mass Tort Update

Janssen Pharmaceuticals was recently ordered to pay more than $10 million to the parents of a child who suffered birth defects due to the epilepsy drug Topamax. The Philadelphia jury found that the company, a unit of Johnson & Johnson, didn’t sufficiently warn doctors about the risk of birth defects stemming from use of the drug.

The North American Antiepileptic Drug Pregnancy Registry found a link between an increased risk of cleft lips and cleft palates to infants who are exposed to Topamax and its generic versions during the early months of pregnancy. The FDA has issued a warning that Topamax increases the risk of certain congenital defects – risks that Janssen Pharmaceuticals knew about years before the drug was prescribed to patients.

If you or someone you know has suffered as a result of the antiepileptic drug Topamax, contact Law Offices of Gary Green today to discuss your legal options without obligation. Call us toll-free at 1-888-4GARYGREEN or email us at gGreen@gGreen.com.

Print Friendly, PDF & Email